Microbial complement inhibitors as vaccines

Vaccine

Volumn 26, Issue SUPPL. 8, 2008, Pages

  Meri, Seppo ^a   Jördens, Markus ^a   Jarva, Hanna ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Borrelia; C4bp; Complement; Factor H; Meningococcus; Yersinia

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT COMPONENT C5; COMPLEMENT FACTOR H; COMPLEMENT INHIBITOR; COMPLEMENT MEMBRANE ATTACK COMPLEX; LIPOPOLYSACCHARIDE; M PROTEIN; PORIN;

ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BORDETELLA PERTUSSIS; BORRELIA BURGDORFERI; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEPOSITION; COMPLEMENT EVASION; COMPLEMENT SYSTEM; IMMUNOGENICITY; IMMUNOSURVEILLANCE; INFLAMMATION; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; VACCINE PRODUCTION; YERSINIA ENTEROCOLITICA; YERSINIA PESTIS;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIA; BACTERIAL PROTEINS; BACTERIAL VACCINES; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; HUMANS;

EID: 57649197924     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.058     Document Type: Article

References (52)

1. Rappuoli R. Bridging the knowledge gaps in vaccine design. Nat Biotechnol 25 12 (2007) 1361-1366
2. He J.Q., Wiesmann C., and van Lookeren Campagne M. A role of macrophage complement receptor CRIg in immune clearance and inflammation. Mol Immunol 45 16 (2008) 4041-4047
3. Walport M. Complement: first of two parts. N Engl J Med 344 (2001) 1058-1066
4. Walport M. Complement: second of two parts. N Engl J Med 344 (2001) 1140-1144
5. Gordon D.L., Kaufman R.M., Blackmore T.K., Kwong J., and Lublin D.M. Identification of complement regulatory domains in human factor H. J Immunol 155 (1995) 348-356
6. Jokiranta T.S., Hellwage J., Koistinen V., Zipfel P.F., and Meri S. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J Biol Chem 275 36 (2000) 27657-27662
7. Lachmann P.J., and Hughes-Jones N.C. Initiation of complement activation. Springer Semin Immunopathol 7 (1984) 143-162
8. Meri S., and Pangburn M.K. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci USA 87 (1990) 3982-3986
9. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., and Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271 5247 (1996) 348-350
10. Fearon D.T., and Carroll M.C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 18 (2000) 393-422
11. Lambris J.D., Ricklin D., and Geisbrecht B.V. Complement evasion by human pathogens. Nat Rev Microbiol 6 2 (2008) 132-142
12. Rautemaa R., and Meri S. Complement-resistance mechanisms of bacteria. Microbes Infect 1 10 (1999) 785-794
13. Alitalo A., Meri T., Rämö L., Jokiranta T.S., Heikkilä T., Seppälä I.J.T., et al. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect Immun 69 6 (2001) 3685-3691
14. Hellwage J., Meri T., Heikkilä T., Alitalo A., Panelius J., Lahdenne P., et al. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 276 11 (2001) 8427-8435
15. Kraiczy P., Skerka C., Kirschfink M., Brade V., and Zipfel P.F. Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and factor H. Eur J Immunol 31 6 (2001) 1674-1684
16. Diaz A., Ferreira A., and Sim R.B. Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. J Immunol 158 8 (1997) 3779-3786
17. Meri T., Hartmann A., Lenk D., Eck R., Würzner R., Hellwage J., et al. The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect Immun 70 9 (2002) 5185-5192
18. Meri T., Jokiranta T.S., Hellwage J., Bialonski A., Zipfel P.F., and Meri S. Onchocerca volvulus microfilariae avoid complement attack by direct binding of factor H. J Infect Dis 185 12 (2002) 1786-1793
19. Berggård K., Johnsson E., Mooi F.R., and Lindahl G. Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect Immun 65 9 (1997) 3638-3643
20. Kirjavainen V., Jarva H., Biedzka-Sarek M., Blom A.M., Skurnik M., and Meri S. Yersinia enterocolitica serum resistance proteins YadA and ail bind the complement regulator C4b-binding protein. PLoS Pathog 4 8 (2008) e1000140
21. Ram S., Cullinane M., Blom A.M., Gulati S., McQuillen D.P., Monks B.G., et al. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med 193 3 (2001) 281-295
22. Thern A., Stenberg L., Dahlbäck B., and Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J Immunol 154 1 (1995) 375-386
23. Lee L.Y., Liang X., Hook M., and Brown E.L. Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). J Biol Chem 279 49 (2004) 50710-50716
24. Hammel M., Sfyroera G., Pyrpassopoulos S., Ricklin D., Ramyar K.X., Pop M., et al. Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. J Biol Chem 282 41 (2007) 30051-30061
25. Sikri N., and Bardia A. A history of streptokinase use in acute myocardial infarction. Tex Heart Inst J 34 3 (2007) 318-327
26. Soulika A.M., Holland M.C., Sfyroera G., Sahu A., and Lambris J.D. Compstatin inhibits complement activation by binding to the beta-chain of complement factor 3. Mol Immunol 43 12 (2006) 2023-2029
27. Jarva H., Jokiranta T.S., Wurzner R., and Meri S. Complement resistance mechanisms of streptococci. Mol Immunol 40 2-4 (2003) 95-107
28. Rooijakkers S.H., and van Strijp J.A. Bacterial complement evasion. Mol Immunol 44 1-3 (2007) 23-32
29. Horstmann R.D., Sievertsen H.J., Knobloch J., and Fischetti V.A. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA 85 5 (1988) 1657-1661
30. Caswell C.C., Han R., Hovis K.M., Ciborowski P., Keene D.R., Marconi R.T., et al. The Scl1 protein of M6-type group A Streptococcus binds the human complement regulatory protein, factor H, and inhibits the alternative pathway of complement. Mol Microbiol 67 3 (2008) 584-596
31. Wei L., Pandiripally V., Gregory E., Clymer M., and Cue D. Impact of the SpeB protease on binding of the complement regulatory proteins factor H and factor H-like protein 1 by Streptococcus pyogenes. Infect Immun 73 4 (2005) 2040-2050
32. Bykowski T., Woodman M.E., Cooley A.E., Brissette C.A., Brade V., Wallich R., et al. Coordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete's mammal-tick infection cycle. Infect Immun 75 9 (2007) 4227-4236
33. Finne J., Bitter-Suermann D., Goridis C., and Finne U. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol 138 12 (1987) 4402-4407
34. Finne J., Leinonen M., and Mäkelä P.H. Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet 2 8346 (1983) 355-357
35. Jarva H., Ram S., Vogel U., Blom A.M., and Meri S. Binding of the complement inhibitor C4 bp to serogroup B Neisseria meningitidis. J Immunol 174 10 (2005) 6299-6307
36. Madico G., Welsch J.A., Lewis L.A., McNaughton A., Perlman D.H., Costello C.E., et al. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177 1 (2006) 501-510
37. Beernink P.T., Welsch J.A., Bar-Lev M., Koeberling O., Comanducci M., and Granoff D.M. Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor H-binding protein. Infect Immun 76 9 (2008) 4232-4240
38. Areschoug T., Stålhammar-Carlemalm M., Karlsson I., and Lindahl G. Streptococcal β protein has separate binding sites for human factor H and IgA-Fc. J Biol Chem 277 15 (2002) 12642-12648
39. Jarva H., Hellwage J., Jokiranta T.S., Lehtinen M.J., Zipfel P.F., and Meri S. The group B streptococcal beta and pneumococcal Hic proteins are structurally related immune evasion molecules that bind the complement inhibitor factor H in an analogous fashion. J Immunol 172 5 (2004) 3111-3118
40. Iannelli F., Oggioni M.R., and Pozzi G. Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. Gene 284 (2002) 63-71
41. Janulczyk R., Iannelli F., Sjöholm A.G., Pozzi G., and Björck L. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J Biol Chem 275 47 (2000) 37257-37263
42. Upadhyay A., Burman J.D., Clark E.A., Leung E., Isenman D.E., van den Elsen J.M., et al. Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi. J Biol Chem 283 32 (2008) 22113-22120
43. McDowell J.V., Harlin M.E., Rogers E.A., and Marconi R.T. Putative coiled-coil structural elements of the BBA68 protein of Lyme disease spirochetes are required for formation of its factor H binding site. J Bacteriol 187 4 (2005) 1317-1323
44. Clantin B., Hodak H., Willery E., Locht C., Jacob-Dubuisson F., and Villeret V. The crystal structure of filamentous hemagglutinin secretion domain and its implications for the two-partner secretion pathway. Proc Natl Acad Sci USA 101 16 (2004) 6194-6199
45. Heffernan E.J., Harwood J., Fierer J., and Guiney D. The Salmonella typhimurium virulence plasmid complement resistance gene rck is homologous to a family of virulence-related outer membrane protein genes, including pagC and ail. J Bacteriol 174 1 (1992) 84-91
46. Heffernan E.J., Wu L., Louie J., Okamoto S., Fierer J., and Guiney D.G. Specificity of the complement resistance and cell association phenotypes encoded by the outer membrane protein genes rck from Salmonella typhimurium and ail from Yersinia enterocolitica. Infect Immun 62 11 (1994) 5183-5186
47. Biedzka-Sarek M., Jarva H., Hyytiainen H., Meri S., and Skurnik M. Characterization of complement factor H binding to Yersinia enterocolitica serotype O:3. Infect Immun 76 9 (2008) 4100-4109
48. Riva R, Holmberg M, Lahteenmaki K, Korhonen T, Meri S. in preparation.
49. Ramu P., Tanskanen R., Holmberg M., Lahteenmaki K., Korhonen T.K., and Meri S. The surface protease PgtE of Salmonella enterica affects complement activity by proteolytically cleaving C3b, C4b and C5. FEBS Lett 581 9 (2007) 1716-1720
50. Cantini F., Savino S., Scarselli M., Masignani V., Pizza M., Romagnoli G., et al. Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis. J Biol Chem 281 11 (2006) 7220-7227
51. Ram S., McQuillen D.P., Gulati S., Elkins C., Pangburn M.K., and Rice P.A. Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J Exp Med 188 4 (1998) 671-680
52. Ram S., Sharma A.K., Simpson S.D., Gulati S., McQuillen D.P., Pangburn M.K., et al. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med 187 (1998) 743-752